期刊文献+

全甲状腺切除对分化型甲状腺癌的临床疗效分析 被引量:2

The influence of total thyroidectomy on the clinical efficacy of differentiated thyroid cancer
下载PDF
导出
摘要 目的:分析全甲状腺切除治疗分化型甲状腺癌的临床疗效。方法:2010年2月-2019年9月收治分化型甲状腺癌患者72例,随机分为两组。对照组实施甲状腺次全切除术治疗;观察组实施甲状腺全切术治疗。比较两组临床疗效。结果:观察组术后30 d治疗总有效率明显高于对照组,差异有统计学意义(P<0.05);观察组术后2年局部复发率及远处转移率均低于对照组,差异有统计学意义(P<0.05)。结论:全甲状腺切除术治疗分化型甲状腺癌,可显著改善患者临床症状,近期疗效和远期疗效均较好,并发症发生风险较低,安全性高。 Objective:To explore the clinical effect of total thyroidectomy on differentiated thyroid cancer.Methods:From February 2010 to September 2019,72 patients with differentiated thyroid cancer were selected and randomly divided into two groups.The control group was treated with subtotal thyroidectomy.The observation group was treated with total thyroidectomy.We compared the clinical efficacy of the two groups.Results:In the observation group,the total effective rate of 30 days after operation was significantly higher than that in the control group,the difference was statistically significant(P<0.05).In the observation group,the local recurrence rate and distant metastasis rate of 2 years after operation were lower than those in the control group,the difference was statistically significant(P<0.05).Conclusion:Total thyroidectomy can significantly improve the clinical symptoms of patients with differentiated thyroid cancer,the short-term and long-term effects are good,the risk of complications is low,and the safety is high.
作者 胡运洲 Hu Yunzhou(Oncology Department,the Second People's Hospital of Tianshui City,Gansu Tianshui 741020)
出处 《中国社区医师》 2020年第26期31-32,共2页 Chinese Community Doctors
关键词 分化型甲状腺癌 全甲状腺切除 并发症 远近期疗效 Differentiated thyroid cancer Total thyroidectomy Complications Long-term and short-term efficacy
  • 相关文献

参考文献12

二级参考文献126

  • 1邢兰兰,陈松,李亚明.分化型甲状腺癌促甲状腺激素抑制治疗的现状及进展[J].中华临床医师杂志(电子版),2012,6(20):159-160. 被引量:17
  • 2曹宏泰,韩继祥,张冬红,俞泽元,王满才,焦作义.甲状腺全切除术治疗多发结节性甲状腺肿的Meta分析[J].中南大学学报(医学版),2014,39(6):625-631. 被引量:44
  • 3许家鹏,徐德龙,梁玉龙,王克诚.分化型甲状腺癌86例手术治疗分析[J].中国肿瘤临床与康复,2006,13(5):464-464. 被引量:7
  • 4Karl Y. Bilimoria,David J. Bentrem,Clifford Y. Ko,Andrew K. Stewart,David P. Winchester,Mark S. Talamonti,Cord Sturgeon.Extent of Surgery Affects Survival for Papillary Thyroid Cancer[J].Annals of Surgery.2007(3)
  • 5Diessl S, Holzberger B, M/ider U, et al. Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma. Clin Endocrinol (OxJ), 2012, 76(4): 586-592.
  • 6Tuttle R, Ball D, Byrd D, et al. NCCN clinical practice guidelines in oncology (NCCN Guidelines'): yroid carcinoma version 2.2012. Fort Washington (PA): National Comprehensive Cancer Network, 2012.
  • 7Gudmundsson J, Sulem P, Gudbjartsson DF, et al. Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet, 2012, 44(3): 319-322.
  • 8Fiore E, Vitti P. Serum TSH and risk of papillary thyroid cancer in nodular thyroid chsease. J Clin Endocrinol Metab, 2012, 97(4): 1134-1145. Sherman SI. Targeted therapies for thyroid tumors. Mod Pathol, 2011, 24(Suppl 2): $44-$52.
  • 9McLeod DS, Watters KF, Carpenter AD, et al. Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. J Clin Endocrinol Metab, 2012, 97(8): 2682-2692.
  • 10Cooper DS. TSH suppressive therapy: an overview of long-term clinical Consequences. Hormones (Athens), 2010, 9(1): 57-59.

共引文献80

同被引文献31

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部